These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38719722)

  • 1. Effect of intravenous immunoglobulin on the management of Rh- and ABO-mediated hemolytic disease of the newborn.
    Jalali SZ; Mahdipour S; Asgarzad R; Saadat F
    Hematol Transfus Cell Ther; 2024 Apr; ():. PubMed ID: 38719722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous Immunoglobulin Use in Hemolytic Disease Due to ABO Incompatibility to Prevent Exchange Transfusion.
    Okulu E; Erdeve O; Kilic I; Olukman O; Calkavur S; Buyukkale G; Cetinkaya M; Ulubas D; Demirel N; Hanta D; Ertugrul S; Gultekin ND; Tuncer O; Demir N; Bilgin L; Narli N; Yildiz D; Terek D; Koroglu OA; Seren C; Ozyazici E; Ozdemir R; Turgut H; Narter F; Akin Y; Ozyazici A; Zenciroglu A; Asker HS; Gokmen Z; Salihli M; Bulbul A; Zubarioglu U; Atasay B; Koc E;
    Front Pediatr; 2022; 10():864609. PubMed ID: 35573949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three or four doses of intravenous immunoglobulin G treatment for isoimmune hemolytic disease: A case series and literature review.
    Zheng Y; Almeyda-Alejo Y; Tumin D; Redpath NSJ; Guillen-Hernandez J
    J Neonatal Perinatal Med; 2024; 17(1):153-158. PubMed ID: 38143377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulin in ABO and Rh hemolytic diseases of newborn.
    Nasseri F; Mamouri GA; Babaei H
    Saudi Med J; 2006 Dec; 27(12):1827-30. PubMed ID: 17143357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
    Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP
    J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility.
    Sarici SU; Yurdakök M; Serdar MA; Oran O; Erdem G; Tekinalp G; Yiğit S
    Pediatrics; 2002 Apr; 109(4):e53. PubMed ID: 11927726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous Immunoglobulins as Adjunct Treatment to Phototherapy in Isoimmune Hemolytic Disease of the Newborn: A Retrospective Case-Control Study.
    Al-Lawama M; Badran E; Elrimawi A; Bani Mustafa A; Alkhatib H
    J Clin Med Res; 2019 Nov; 11(11):760-763. PubMed ID: 31803318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin for alloimmune hemolytic disease in neonates.
    Zwiers C; Scheffer-Rath ME; Lopriore E; de Haas M; Liley HG
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD003313. PubMed ID: 29551014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Intravenous Immunoglobulin Administration for Hyperbilirubinemia in Newborn Infants with Hemolytic Disease.
    Mohan DR; Lu H; McClary J; Marasch J; Nock ML; Ryan RM
    Children (Basel); 2023 Mar; 10(3):. PubMed ID: 36980054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy and safety of intravenous immunoglobulins in the management of neonatal hyperbilirubinemia due to ABO incompatibility: a meta-analysis].
    Cortey A; Elzaabi M; Waegemans T; Roch B; Aujard Y
    Arch Pediatr; 2014 Sep; 21(9):976-83. PubMed ID: 25125032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive Direct Antiglobulin Test: Is It a Risk Factor for Significant Hyperbilirubinemia in Neonates with ABO Incompatibility?
    Ercin S; Coskun Y; Kayas K; Kavas N; Gursoy T
    Am J Perinatol; 2024 Mar; 41(4):505-510. PubMed ID: 34847590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of the development of neonatal hyperbilirubinemia in ABO incompatibility.
    Chen JY; Ling UP
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Jan; 53(1):13-8. PubMed ID: 8173995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Spectrum of Hemolytic Disease of the Newborn: Evaluating the Etiology of Unconjugated Hyperbilirubinemia Among Neonates Pertinent to Immunohematological Workup.
    Routray SS; Behera R; Mallick B; Acharya D; Sahoo JP; Kanungo GN; Pati B
    Cureus; 2021 Aug; 13(8):e16940. PubMed ID: 34513509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective analysis of direct antiglobulin test positivity at tertiary academic hospital over 10 years.
    Rahmati A; Farhat AS; Boroumand-Noughabi S; Soleymani F; Keramati M
    Transfus Apher Sci; 2022 Jun; 61(3):103358. PubMed ID: 35074271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Description of IVIG Use in Term Neonates with ABO Incompatibility.
    Daunov M; Schlosser A; Malay S; Adams J; Clark R; Ferrerosa L; Pateva I
    Am J Perinatol; 2024 Mar; ():. PubMed ID: 38286423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in hospitalizations of newborns with hyperbilirubinemia and kernicterus in United States: an epidemiological study.
    Vidavalur R; Devapatla S
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7701-7706. PubMed ID: 34470114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous immunoglobulin in hemolytic disease of the newborn: A moving target in time.
    Vardar G; Okan MA; Karadag N; Topcuoglu S; Ozalkaya E; Karatepe HO; Karatekin G
    Niger J Clin Pract; 2022 Aug; 25(8):1262-1268. PubMed ID: 35975373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ABO hemolytic disease of the fetus and newborn: thirteen years of data after implementing a universal bilirubin screening and management program.
    Christensen RD; Baer VL; MacQueen BC; O'Brien EA; Ilstrup SJ
    J Perinatol; 2018 May; 38(5):517-525. PubMed ID: 29410540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulin G in the treatment of ABO hemolytic disease of the newborn during the early neonatal period at a tertiary academic hospital: a retrospective study.
    Pan J; Zhan C; Yuan T; Chen X; Ni Y; Shen Y; Chen W; Wu T; Yu H
    J Perinatol; 2021 Jun; 41(6):1397-1402. PubMed ID: 33589732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sn-Mesoporphyrin interdiction of severe hyperbilirubinemia in Jehovah's Witness newborns as an alternative to exchange transfusion.
    Kappas A; Drummond GS; Munson DP; Marshall JR
    Pediatrics; 2001 Dec; 108(6):1374-7. PubMed ID: 11731664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.